Product news

Share this article:
Johnson & Johnson's anemia drug Procrit has been linked to death in some patients, according to a new study. In the study, which was designed and initiated by a German scientist, more patients treated with Eprex (Procrit's name outside the US) died than in the comparison group receiving a placebo.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions